Jennison Associates
TMDX icon

Jennison Associates’s Transmedics TMDX Stock Holding History

Jennison Associates’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9,217
Closed -$620K – 632
2025
Q1 		$620K Buy
9,217
+316
+4% +$21.7K ﹤0.01% 531
2024
Q4 		$555K Buy
+8,901
New +$829K ﹤0.01% 547
2023
Q3 		– Sell
-4,236
Closed -$356K – 603
2023
Q2 		$356K Sell
4,236
-52
-1% -$3.98K ﹤0.01% 551
2023
Q1 		$325K Buy
+4,288
New +$297K ﹤0.01% 570

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jennison Associates's TMDX Position: Q2 2025 in Review

Jennison Associates sold out of Transmedics (TMDX) in Q2 2025, closing a stake of 9,217 shares — an estimated $620K sold.

Jennison Associates first reported a position in TMDX in Q1 2023 and held it in 4 quarters. The position peaked at $620K in Q1 2025. 368 funds tracked by Wall St. Rank hold TMDX as of Q2 2025.

  • Jennison Associates reported no remaining Transmedics position as of Q2 2025 after selling out during the quarter.
  • Jennison Associates sold 9,217 Transmedics shares in Q2 2025, an estimated $620K.
  • Jennison Associates first reported a position in Transmedics in Q1 2023 and held it in 4 quarters.
  • Jennison Associates's Transmedics position peaked at $620K in Q1 2025.
  • 368 funds tracked by Wall St. Rank held Transmedics as of Q2 2025.

Based on Jennison Associates's 13F filing for Q2 2025, filed 1 Aug 2025.